BSEBoard Meeting23h ago · 21 Jul 2026, 05:31 pm
Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
Shree Ganesh Biotech (India) Ltd · 539470
✦ AI SummaryResults
Shree Ganesh Biotech (India) Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 04/08/2026 to consider and approve the Un-Audited Financial Results for the first quarter ended on 30th June 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Shree Ganesh Biotech (India) Ltd - 539470 - Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.
Attachments (1)
📄pdf
Download →
ab39b034-e5f0-4a14-8893-959d4e0d4f17.pdf
View document text
SHR EE G AN ESH BI O - T E C H (I ND I A) L I M I TED
CIN: L70101WB1982PLC121196
Reg. Office: CUBICLE NO.: 126, 3/2, 75C, PARK STREET, 3RD FLOOR, KAMDHENU BUILDING, KOLKATA -700016
Email: shreeganeshbiotechindialtd@gmail.com Website: www.shreeganeshbiotech.shop
Date: 21.07.2026
To, To, To,
Listing Department, The Secretary, Head - Listing
BSE Limited, . The Calcutta Stock Exchange Ltd, Metropolitan Stock
P J Tower, Dalal Street 7, Lyons Range, Exchange of India Limited
Mumbai-400001 Kolkata - 700001 Vibgyor Towers, 4th floor,
Plot Noe 62, Opp. Trident
Hotel Bandra Kurla Complex,
Bandra (E)
Mumbai - 400098
Scrip Code: 539470 Scrip Code: 29221 Scrip Code-SHREEGANES
Sub: Compliance of Regulation 29 of SEBI (LODR) Regulations, 2015 - Intimation of Board meeting.
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,
we would like to inform you that a meeting of the Board of Directors of the Company will be held on
Tuesday 4th August 2026 inter alia, to consider following businesses: -
1.) To approve and take on record the Un-Audited Financial Results of the Company for the first quarter
ended on 30th June 2026.
2.) Any other matter with the permission of the board which the Board may think fit.
Please take the above intimation in your records.
Thanking You.
Yours Faithfully,
FOR, SHREE GANESH BIO-TECH (INDIA)LIMITED
AMAN PATEL
DIRECTOR